Israel - Ibrani - Ministry of Health

inovamed pharma ltd, israel - carbidopa; entacapone; levodopa - טבליות מצופות פילם - levodopa 50 mg; carbidopa 12.5 mg; entacapone 200 mg - levodopa and decarboxylase inhibitor - levodopa and decarboxylase inhibitor - treatment of patients with parkinson's disease and end-of-dose motor fluctuations not stabilised on levodopa/dopa decarboxylase (ddc) inhibitor treatment.

Israel - Ibrani - Ministry of Health

vetmarket ltd, israel - butorphanol as tartrate - תמיסה להזרקה - butorphanol as tartrate 10 mg/ml

Israel - Ibrani - Ministry of Health

megapharm ltd - anakinra - תמיסה להזרקה - anakinra 150 mg/ml - anakinra - anakinra - kineret is indicated for the treatment of the signs and symptoms of rheumatoid arthritis in combination with methotrexate, in patients with an inadequate response to methotrexate alone.

Israel - Ibrani - Ministry of Health

teva pharmaceutical indust.ltd - dexamethasone sodium phosphate 20 mg/ml - solution for injection - dexamethasone - intravenous use as adjunctive treatment of severe shock of hemorrhagic, traumatic, surgical or septic origin.

Israel - Ibrani - Ministry of Health

teva pharmaceutical industries ltd, israel - dexamethasone sodium phosphate - תמיסה להזרקה - dexamethasone sodium phosphate 20 mg/ml - dexamethasone - dexamethasone - intravenous use as adjunctive treatment of severe shock of hemorrhagic, traumatic, surgical or septic origin.

Israel - Ibrani - Ministry of Health

lapidot medical import and marketing ltd - diclofenac sodium 75 mg / 3 ml - solution for injection - diclofenac - exacerbations of inflammatory and degenerative forms of rheumatism : rheumatoid arthritis ankylosing spondylitis, osteoarthritis, spondylarthritis non-articular rheumatism. treatment of painful conditions due to inflammation of non rheumatic origin. renal colic and biliary colic. post- traumatic and post-operative pain, inflammation and swelling.

Israel - Ibrani - Ministry of Health

glaxo smith kline (israel) ltd - paroxetine as hydrochloride 20 mg - tablets - paroxetine - treatment of symptoms of depressive illness of all types including depression accompanied by anxiety. treatment of symptoms and prevention of relapse of obsessive compulsive disorder (ocd). treatment of symptoms and prevention of relapse of panic disorder with or without agoraphobia.treatment of symptoms of social phobia. post traumatic stress disorder. generalised anxiety disorders.

Israel - Ibrani - Ministry of Health

glaxo smith kline (israel) ltd - paroxetine as hydrochloride 20 mg - tablets - paroxetine - treatment of symptoms of depressive illness of all types including depression accompanied by anxiety. treatment of symptoms and prevention of relapse of obsessive compulsive disorder (ocd). treatment of symptoms and prevention of relapse of panic disorder with or without agoraphobia.treatment of symptoms of social phobia. post traumatic stress disorder. generalised anxiety disorders.

Israel - Ibrani - Ministry of Health

pfizer pharmaceuticals israel ltd - paroxetine hydrochloride hemihydrate 20 mg - film coated tablets - paroxetine - treatment of symptoms of depressive illness of all types including depression accompanied by anxiety. treatment of symptoms and prevention of relapse of obsessive compulsive disorder (ocd). treatment of symptoms and prevention of relapse of panic disorder with or without agoraphobia.treatment of symptoms of social phobia. post traumatic stress disorder. generalised anxiety disorders.

Israel - Ibrani - Ministry of Health

pfizer pharmaceuticals israel ltd - paroxetine hydrochloride hemihydrate 30 mg - film coated tablets - paroxetine - treatment of symptoms of depressive illness of all types including depression accompanied by anxiety. treatment of symptoms and prevention of relapse of obsessive compulsive disorder (ocd). treatment of symptoms and prevention of relapse of panic disorder with or without agoraphobia.treatment of symptoms of social phobia. post traumatic stress disorder. generalised anxiety disorders.